- Home
- VYNE vs YCBD Comparison
VYNE vs YCBD Comparison
Compare VYNE & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- YCBD
- Stock Information
- Founded
- VYNE 2003
- YCBD 2015
- Country
- VYNE United States
- YCBD United States
- Employees
- VYNE N/A
- YCBD N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- VYNE Health Care
- YCBD Health Care
- Exchange
- VYNE Nasdaq
- YCBD Nasdaq
- Market Cap
- VYNE 9.6M
- YCBD 7.8M
- IPO Year
- VYNE 2018
- YCBD N/A
- Fundamental
- Price
- VYNE $0.35
- YCBD $1.03
- Analyst Decision
- VYNE Buy
- YCBD Strong Buy
- Analyst Count
- VYNE 2
- YCBD 1
- Target Price
- VYNE $8.00
- YCBD $2.00
- AVG Volume (30 Days)
- VYNE 3.1M
- YCBD 1.1M
- Earning Date
- VYNE 11-10-2025
- YCBD 12-17-2025
- Dividend Yield
- VYNE N/A
- YCBD N/A
- EPS Growth
- VYNE N/A
- YCBD N/A
- EPS
- VYNE N/A
- YCBD N/A
- Revenue
- VYNE $476,000.00
- YCBD $19,026,064.00
- Revenue This Year
- VYNE N/A
- YCBD $0.37
- Revenue Next Year
- VYNE N/A
- YCBD $4.95
- P/E Ratio
- VYNE N/A
- YCBD N/A
- Revenue Growth
- VYNE N/A
- YCBD N/A
- 52 Week Low
- VYNE $0.28
- YCBD $0.59
- 52 Week High
- VYNE $4.30
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- VYNE 45.50
- YCBD 48.08
- Support Level
- VYNE $0.34
- YCBD $0.94
- Resistance Level
- VYNE $0.38
- YCBD $1.09
- Average True Range (ATR)
- VYNE 0.03
- YCBD 0.15
- MACD
- VYNE 0.00
- YCBD -0.04
- Stochastic Oscillator
- VYNE 21.78
- YCBD 13.73
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.